Merck KGaA Company Profile (OTCMKTS:MKGAY)

Analyst Ratings

Consensus Ratings for Merck KGaA (OTCMKTS:MKGAY) (?)
Ratings Breakdown: 6 Hold Rating(s), 6 Buy Rating(s)
Consensus Rating:Buy (Score: 2.50)
Consensus Price Target: $59.60

Analysts' Ratings History for Merck KGaA (OTCMKTS:MKGAY)
Show:
DateFirmActionRatingPrice TargetActions
5/25/2016DZ Bank AGReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/19/2016JPMorgan Chase & Co.Reiterated RatingNeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/17/2016Citigroup Inc.Reiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/9/2016Credit Suisse Group AGReiterated RatingNeutral$56.00 -> $57.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/16/2016Jefferies GroupReiterated RatingHold$51.00 -> $54.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/8/2016Nord/LBReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/8/2016Deutsche Bank AGReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/6/2016Goldman Sachs Group Inc.Reiterated RatingNeutral$60.00 -> $56.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/27/2016Bank of America Corp.Reiterated RatingNeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/1/2015Barclays PLCUpgradeEqual Weight -> Overweight$64.00 -> $66.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/17/2015ArgusReiterated RatingBuy$70.00 -> $65.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/26/2015Societe GeneraleReiterated RatingNeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/2/2015Piper Jaffray Cos.Reiterated RatingUnderweightView Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/25/2015HSBCInitiated CoverageHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/29/2015BNP ParibasInitiated CoverageNeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/29/2014 forward)

Earnings

Earnings History for Merck KGaA (OTCMKTS:MKGAY)
No earnings announcements for this company have been tracked by MarketBeat.com

Estimates

Earnings Estimates for Merck KGaA (OTCMKTS:MKGAY)
No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for Merck KGaA (OTCMKTS:MKGAY)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Merck KGaA (OTCMKTS:MKGAY)
No insider trades for this company have been tracked by MarketBeat.com

Headlines

Latest Headlines for Merck KGaA (OTCMKTS:MKGAY)
DateHeadline
07/29/16 05:21 PMMerck posts better-than-expected quarterly profit, revenue
07/28/16 01:08 AMMerck and AmoyDx Collaborate to Bring Liquid Biopsy RAS Biomarker Testing to China - [at noodls] - News Release YourConta ct Rimmi H arindran +49 6151 72-32843 Liquid biopsy RAS biomarker test based upon AmoyDx's real-time PCR technology, ADx-SuperARMS®, will be made available in China in 2017 ... This ...
07/26/16 08:08 AMMerck Biopharma Innovation Cup Honors Young Scientists - [at noodls] - News Release Your Contact Heather Connor +1 978-294-1660 July 26, 2016 Winning team receives €20,000 for an innovative project proposal on schistosomiasis vector control Darmstadt, Germany, July 26, 2016 ...
07/18/16 10:30 AMMerck KGaA's marketing application for Cladribine tablets accepted for review in Europe
07/18/16 02:38 AMMerck Receives European Medicines Agency Acceptance for Review of Marketing Authorization Application for Cladribine Tablets - [at noodls] - Press Release Template News Release Your Contact Gangolf Schrimpf +49 6151 72-9591 Investor Relations +49 6151 72-3321 July 18, 2016 Darmstadt, Germany, July 18, 2016 - Merck, a leading science and technology... ...
07/15/16 07:58 AMDietmar Eidens Appointed Chief HR Officer (CHRO) of Merck - [at noodls] - 20160715_Press_Release_Merck_Eidens_Head_HR_en News Release Your Contact Gangolf Schrimpf +49 6151 72-9591 July 15, 2016 Kai Beckmann retains Executive Board responsibility for Group Human Resources Darmstadt, ...
07/13/16 07:13 AMMerck Advances Water Purification Systems with New High-Throughput Line - [at noodls] - 84105619-a6f7-4c92-ac78-16e08a9873f2.pdf News Release Your Contact Karen Tiano + 1 978 495 0093 July 13, 2016 Merck Advances Water Purification Systems with New High- Throughput Line Elix® High-Throughput ...
07/12/16 07:03 AMMerck Expands Excipients Portfolio, Adding Polymers for Sustained Release Injectables - [at noodls] - a7c1fdf9-bf96-4d1d-a55a-8f4b4be0e4d2.pdf News Release Your Contact Karen Tiano +1 978 495 0093 July 12, 2016 Allows for more precise control of release kinetics Enables... This is an abstract of the original ...
07/07/16 05:13 PMLate-stage study commences assessing Merck KGaA and Pfizer's avelumab + chemo in advanced ovarian cancer
07/06/16 07:11 AMMerck and Pfizer Initiate Phase III Trial to Evaluate Avelumab as First-line Treatment for Ovarian Cancer - [at noodls] - Press Release Template News Release Merck Media: Gangolf Schrimpf +49 6151 72 9591 Investor Relations: +49 6151 72 3321 Pfizer Media:... This is an abstract of the original noodl. To continue reading this ...
07/06/16 01:11 AMMerck Commits €1.5 million to the Grant for Fertility Innovation (GFI) for 2016/17 - [at noodls] - Press Release Template News Release Your Contact Heather Connor +1 978 294-1660 July 6, 2016 Investment reflects company's commitment to innovation in fertility research ... This is an abstract of the ...
07/05/16 05:00 PMOneCrinone reproductive treatment approved in Japan
07/05/16 07:58 AMJuniper Pharmaceuticals Says Merck, Germany, Gets Japan's Regulatory Approval For OneCrinone - Juniper Pharmaceuticals, Inc. (NASDAQ: JNP) revealed that Merck KGaA, Darmstadt, Germany has got the approval of the regulator for its OneCrinone 90 mg (progesterone) for the indication of luteal phase supplementation in assisted reproductive treatment. The approval is meant ...Full story available on Benzinga.com
07/01/16 07:41 AMMerck and University of Nairobi to Start Medical Oncology Fellowship Program - [at noodls] - Press Release Template News Release Your Contact Neetha Mahadevan +49 6151 72-6328 Grace Mukasa +254 20 271 4617 July 1, 2016 Program aims to improve access to cancer care in Africa and... This is an abstract ...
07/01/16 05:48 AM6:48 am Merck KGaA to present data from the pivotal Phase III TAILOR study in patients from China -
07/01/16 03:41 AMResults of Pivotal TAILOR Study Confirm Addition of Erbitux to FOLFOX Significantly Improves Outcomes in RAS Wild-Type Metastatic Colorectal Cancer - [at noodls] - fda6b8d4-c430-45db-9018-2f175e2df248.pdf News Release YourCont act Heike S chmiedt +49 6151 72-7498 July 1, 2016 WCGC Abstract # 0-025; poster presentation, July 1, 2016,... This is an abstract of the ...
07/01/16 01:11 AMSuccessful Cooperation Between Merck and Agrimer in Marine-Derived Dermocosmetic Active Ingredients - [at noodls] - 160630_PM_final_EN News Release Your contact Nina Diergardt +49 6151 72-7589 July 1, 2016 Long-term partnership for innovative ingredients from the sea RonaCare® RenouMer is the first product developed ...
06/30/16 02:48 AMBRIEF-Merck KGaA says Zeiss, Hamilton Thorne to join global fertility alliance - * Says welcomes Zeiss and Hamilton Thorne as new members of global fertility alliance Source text for Eikon: Further company coverage:
06/30/16 02:15 AMMerck KGaA, Darmstadt, Germany, Welcomes ZEISS and Hamilton Thorne as New Members of the Global Fertility Alliance - [PR Newswire] - Merck KGaA, Darmstadt, Germany, a leading science and technology company, today announced together with Illumina Inc., San Diego, US, and Genea Limited, Sydney, Australia, that the Global Fertility Alliance welcomed two new members. The alliance is a collaboration to advance excellence in fertility technologies and processes within the assisted reproductive treatment (ART) laboratory.
06/30/16 02:11 AMMerck Welcomes ZEISS and Hamilton Thorne as New Members of the Global Fertility Alliance - [at noodls] - Microsoft Word - Press Release Global Fertility Alliance New Members_final 29 Jun 2016.docx News Release Your Contact Bettina Frank +49 6151 72-4660 June 30, 2016 Not intended for U.S. based media New ...
06/29/16 01:11 AMMerck Receives Frost & Sullivan Award for Meoxal® and Xirallic® NXT Lines - [at noodls] - PM_FuSAward_E News Release Your contact Nina Diergardt +49 6151 72-7589 June 29, 2016 Merck Receives Frost & Sullivan Award for Meoxal® and Xirallic® NXT Lines Product Leadership Award 2016 for staying ...
06/28/16 07:11 AMMerck Expands Industry-Leading Emprove® Program to Include Filtration and Single-Use Products - [at noodls] - b52b8ee4-b428-424a-bd99-c8d4f7e80851.pdf News Release Your Contact Karen Tiano +1 978 495 0093 June 28, 2016 Merck Expands Industry-Leading Emprove® Program to Include Filtration and Single-Use Products ...
06/28/16 04:11 AMMerck to Develop Next-Generation Purification Processes with International Vaccine Institute - [at noodls] - 8a0eeeac-8bae-453e-8244-6b9ff8747262.pdf Your Contact News Release June 28, 2016 Karen Tiano +1 978 495 0093 Company to provide expertise on clarification and purification Collaboration will improve manufacturing ...
06/25/16 08:57 AMEylea Combinations And Array's Play For Melanoma
06/20/16 01:49 PMETF’s with exposure to Merck KGaA : June 20, 2016 -
06/17/16 07:19 AMMerck Family Foundation Established - [at noodls] - Press Release Template News Release Your Contact Gangolf Schrimpf +49 6151 72-9591 June 17, 2016 The Merck family of owners combines its charitable activities under one roof ... This is an abstract of ...
06/13/16 04:49 PMMerck KGaA In Deal With HAPPYneuron To Offer E-Health Solution For MS Patients
06/13/16 02:09 AMMerck in Agreement with HAPPYneuron to Offer First-of-its Kind e-Health Solution for People Living with Multiple Sclerosis - [at noodls] - Press Release Template News Release Your Contact Stephen McGettrick +1-781-681-2104 June 13, 2016 Agreement provides Merck with exclusive license to cognitive remediation training programs ... This is ...
06/09/16 03:09 AMConsumer Health To Play A Pivotal Role In Merck’s Africa Growth Strategy - [at noodls] - 7febf971-4bc9-47c0-97f7-850fb5ddef50.pdf News Release Your Contact Lars Atorf +49 6151 856 3114 June 9, 2016 Consumer Health To Play A Pivotal Role In Merck's Africa Growth Strategy Consumer Health at ...
06/09/16 02:09 AMMerck Accelerator Expands its Reach to Silicon Valley - [at noodls] - 0d358591-11f1-4189-ad0f-743f3e568f82.pdf News Release Your Contact Annika Zille +49 151 1454 1110 June 9, 2016 Global application period for Accelerator programs in Darmstadt and Nairobi starts today ... ...
06/08/16 04:08 AMMerck Expands its Investment Fund Merck Ventures - [at noodls] - Press Release Template News Release Your Contact Gangolf Schrimpf +49 6151 72-9591 June 8, 2016 Existing biopharma venture fund renamed and expanded to all Merck business sectors ... This is an abstract ...
06/07/16 01:08 AMMerck Announces Survey Results Exploring Biopharma Industry’s Evolving Risk Model - [at noodls] - ff4b8f20-446d-410a-ba92-f1ce6af4c66b.pdf Your Contact News Release June 7, 2016 Karen Tiano +1 978 495 0093 Merck Announces Survey Results Exploring Biopharma Industry's Evolving Risk Model Study highlights ...
06/06/16 08:54 AMPfizer Says Pivotal Avelumab Study Shows Positive Results In MCC
06/06/16 08:08 AMASCO 2016: Pivotal Avelumab Study Shows Positive Results in Metastatic Merkel Cell Carcinoma - [at noodls] - Press Release Template News Release Merck Media: Gangolf Schrimpf +49 151 1454 9591 Investor Relations: +49 6151 72 3321 Pfizer Media:... This is an abstract of the original noodl. To continue reading ...
06/04/16 09:05 AMBRIEF-Merck KGaA partners with Array BioPharma, Pierre Fabre on mCRC phase iii trial - * Says partners with Array BioPharma and Pierre Fabre to initiate braf-mutant mCRC phase iii trial Further company coverage:
06/01/16 08:23 AMMerck’s Belén Garijo Receives Prestigious Career Award - [at noodls] - Press Release Template News Release Your Contact Gangolf Schrimpf +49 6151 72-9591 June 1, 2016 Merck's Belén Garijo Receives Prestigious Career Award Award from non-profit Spanish foundation Fundamed... ...
05/26/16 11:04 AMMerck KGaA :MKGAY-US: Earnings Analysis: Q1, 2016 By the Numbers : May 26, 2016 -
05/26/16 09:43 AMCancer Immunotherapies Take Center Stage in Pre-ASCO Abstract Releases -
05/19/16 02:22 AMMerck KGaA reports Q1 results -
05/18/16 04:12 PMMerck and Pfizer to Present Avelumab Data in Seven Different Cancers at ASCO Annual Meeting - [at noodls] - Press Release Template News Release Merck Media: Gangolf Schrimpf +49 6151 72 9591 Investor Relations: +49 6151 72 3321 Pfizer Media:... This is an abstract of the original noodl. To continue reading this ...
05/18/16 04:12 PMBringing Innovation to Patients: Merck Presents New Advances at ASCO 2016 - [at noodls] - Press Release Template News Release Merck Media: Gangolf Schrimpf +49 6151 72 9591 Investor Relations: +49 6151 72 3321 Pfizer Media:... This is an abstract of the original noodl. To continue reading this ...
05/13/16 03:08 AMGerman Image Award Goes to former Merck CEO Karl-Ludwig Kley and former Chief Communications Officer Chief Walter Huber - [at noodls] - Press Release Template News Release Your Contact Gangolf Schrimpf +49 6151 72-9591 May 13, 2016 Prize for best international media image Darmstadt, Germany, May 13, 2016 - Merck, a... This is an abstract ...
05/11/16 07:52 AMMerck Expands Popular Line of Guava® Flow Cytometers - [at noodls] - ff67fa81-b0ac-441b-8271-54f0ecd8a3e3.pdf Your Contact News Release May 11, 2016 Karen Tiano +1 978 495 0093 Merck Expands Popular Line of Guava® Flow Cytometers Optical configurations meet needs of any ...
05/10/16 09:28 AMMerck Showcases New Innovations at Analytica 2016 - [at noodls] - 049d6388-8980-48cb-b4d1-b5a253af461d.pdf News Release Your Contact Karen Tiano +1 978 495 0093 May 10, 2016 Life science expertise and innovations for simplified, dynamic and precise live cell analysis ...
05/10/16 03:08 AMMerck High-Tech for the Automotive Industry - [at noodls] - Merck Press Release Automotive Interior Stuttgart News Release Your contact Judith Rahner +49 6151 72-7694 May 10, 2016 Digital concept car featuring innovative high-tech materials to be introduced at ...
05/09/16 08:08 AMMerck and Progyny Extend Collaboration for Eeva® Software to Global Level - [at noodls] - Microsoft Word - Merck Progyny Global Collaboration_5 May 2016_final.docx News Release Your Contact Bettina Frank +49 6151 72-4660 May 09, 2016 Merck and Progyny Extend Collaboration for Eeva® Software ...
05/09/16 07:08 AMMerck Launches First Commercially Available Equine-Specific Multiplex Assay for Protein Biomarkers - [at noodls] - 125b5d02-8abc-416b-af48-4a3e86cd3c28.pdf News Release Your Contact Karen Tiano +1 978 495 0093 May 9, 2016 Merck Launches First Commercially Available Equine- Specific Multiplex Assay for Protein Biomarkers ...
05/04/16 07:10 AMMerck Builds on Leading Viral and Gene Therapy Service Offering with Capacity Expansion - [at noodls] - fa9ee4e2-810b-4b3e-bae7-ba533746593f.pdf Your Contact News Release May 4, 2016 Neetha Mahadevan 06151 726328 Larger Carlsbad, California facility will allow seamless scale-up customer support from clinical ...
05/04/16 02:10 AMMerck at SID: Materials for the Displays of Today and Tomorrow - [at noodls] - Merck SID Press Release 2016 News Release Your contact Judith Rahner +49 6151 72-7694 May 4, 2016 New materials can further optimize display properties OLED technology is... This is an abstract of the ...
03/08/16 02:20 AMUPDATE 1-Merck KGaA aims for 2016 earnings growth thanks to takeover - * Sees low double-digit percentage gain for 2016 core earnings

Social

About Merck KGaA

Merck KGaA logoMerck KGaA is a Germany-based company engaged in the pharmaceutical industry. The Company diversifies its activities into four business divisions: Merck Serono; Consumer Health; Merck Millipore, and Performance Materials. Within the Merck Serono division, the Company focuses on therapeutic areas and prescription drugs of chemical and biotechnological origin. The Consumer Health division comprises the over-the-counter products for preventive health care and self-treatment of minor ailments. The Merck Serono and Consumer Health divisions form together the Company's Pharmaceutical business sector. The Merck Millipore division comprises the activities of the Millipore Corporation. The Performance Materials division consists mainly of the Liquid Crystals and Pigments & Cosmetics business units. The Company operates through numerous subsidiaries, including Peer+ BV, AZ Electronic Materials (AZ) and Ormet Circuits Inc., a material supplier for the semiconductor industry.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: N/A
  • Sub-Industry: N/A
  • Exchange: OTCMKTS
  • Symbol: MKGAY
  • CUSIP:
Key Metrics:
  • Previous Close: $36.81
  • 50 Day Moving Average: $34.01
  • 200 Day Moving Average: $30.77
  • P/E Ratio: 30.77
  • P/E Growth: 2.28
  • Market Cap: $48.06B
  • Current Year EPS Consensus Estimate: $6.48 EPS
  • Next Year EPS Consensus Estimate: $6.75 EPS
Additional Links:
Merck KGaA (OTCMKTS:MKGAY) Chart for Friday, July, 29, 2016